JCN Newswire Read More Eisai Presents New Findings for Antibody Drug Conjugate Farletuzumab Ecteribulin at 2022 ASCO Annual Meeting ruth 6 6 月 5 minutes TOKYO, Jun 6, 2022 – (JC […]
